Skip to contentC
Catheter Precision, Inc.
C
VJETCatheter Precision, Inc. Q1 2024 · 10-Q
Revenue$82.00K$82.00K−3.5% vs Q1 2023 Net Income-$2.68M-$2.68MN/M vs Q1 2023 EPS, diluted—
Operating Income-$2,616,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Catheter Precision, Inc. · CIK 1716621 · Engraved from SEC EDGAR
Operating Cash Flow-$1,942,000N/M Free Cash Flowderived-$1,964,000N/M Margins · derivedGross margin93.9%+5.7 pt vs Q1 2023
Operating margin-3190.2%+75026.2 pt vs Q1 2023
Net margin-3262.2%+74855.5 pt vs Q1 2023
ended Mar 31, 2024 · filed May 6, 2024 · 36 d after period end